TCL Archive FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy October 26, 2007
TCL Archive ‘We Cannot Tolerate One Third Reduction In Centers. Prevention, Clinical Trials Programs’ September 20, 1991